HBM HEALTHCARE INVESTMENTS AG

(HBMN)
  Report
Delayed Swiss Exchange  -  05/16 03:50:59 am EDT
252.50 CHF   +3.48%
05/10Pfizer to acquire HBM portfolio company Biohaven Pharmaceuticals in USD 11.6 billion deal
EQ
05/06HBM Healthcare Investments Sinks To FY22 Loss On Negative Result From Investment Activities
MT
05/06HBM Healthcare Investments year-end results 2021/2022
EQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

HBM Healthcare Investments's Fiscal Q3 Profit Sinks Amid Bearish Market

01/21/2022 | 01:09am EDT


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
HBM HEALTHCARE INVESTMENTS AG 3.48% 252.5 Delayed Quote.-28.02%
HBM HOLDINGS LIMITED -0.29% 3.46 Delayed Quote.-55.23%
All news about HBM HEALTHCARE INVESTMENTS AG
05/10Pfizer to acquire HBM portfolio company Biohaven Pharmaceuticals in USD 11.6 billion de..
EQ
05/06HBM Healthcare Investments Sinks To FY22 Loss On Negative Result From Investment Activi..
MT
05/06HBM Healthcare Investments year-end results 2021/2022
EQ
05/02HBM Healthcare Investments Sees 3% Drop in April NAV
MT
05/02HBM HEALTHCARE INVESTMENTS : Key Figures 30.04.2022
PU
05/02Key Figures 30.04.2022
EQ
04/19HBM HEALTHCARE INVESTMENTS : Key Figures 15.04.2022
PU
04/19Key Figures 15.04.2022
EQ
04/03HBM Healthcare Investments' NAV Slips 4% In FY22
MT
04/01HBM HEALTHCARE INVESTMENTS : Key Figures 31.03.2022
PU
More news
Analyst Recommendations on HBM HEALTHCARE INVESTMENTS AG
More recommendations
Financials
Sales 2022 267 M 267 M 267 M
Net income 2022 214 M 214 M 214 M
Net cash 2022 158 M 158 M 158 M
P/E ratio 2022 7,92x
Yield 2022 5,12%
Capitalization 1 698 M 1 696 M 1 696 M
EV / Sales 2022 5,77x
EV / Sales 2023 3,70x
Nbr of Employees 700
Free-Float 83,8%
Chart HBM HEALTHCARE INVESTMENTS AG
Duration : Period :
HBM Healthcare Investments AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HBM HEALTHCARE INVESTMENTS AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 244,00 CHF
Average target price 370,00 CHF
Spread / Average Target 51,6%
EPS Revisions
Managers and Directors
Andreas Wicki Chief Executive Officer
Erwin Troxler Chief Financial Officer
Hans-Peter Hasler Chairman
Rudolf Lanz Director
Mario Germano Giuliani Director